DOSE RESPONSE RELATIONSHIP OF NEUROMUSCULAR BLOCKADE, INTUBATION CONDITIONS AND CARDIOVASCULAR CHANGES WITH...

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Neuromuscular blocking agents are crucial in general anesthesia.
• Chandonium iodide is a novel neuromuscular blocking agent requiring dose-response evaluation.

Purpose of the Study:

• To determine the dose-response relationship of intravenous chandonium iodide.
• To evaluate its efficacy and safety for general anesthesia and gynecological surgery.

Main Methods:

• 140 ASA physical status I and II patients were randomized into five groups.
• Patients received varying doses (100-250 µg/kg) of chandonium iodide intravenously.
• Neuromuscular blockade was assessed clinically and via train-of-four using a myotest nerve stimulator.

Main Results:

• Increasing chandonium iodide dosage significantly decreased onset time for jaw relaxation and apnea (p<0.01).
• Neuromuscular blockade duration increased linearly with dosage, from 10.90 ± 5.31 to 25.18 ± 7.15 min.
• Ideal intubation conditions were achieved in 100% of patients at 200 µg/kg, with overall improvement across groups.
• Recovery was rapid and smooth, with transient, non-dose-dependent increases in heart rate and blood pressure.

Conclusions:

• Chandonium iodide provides effective neuromuscular blockade with dose-dependent effects on onset and duration.
• 200 µg/kg of chandonium iodide is optimal for achieving excellent intubation conditions.
• The agent is safe, with rapid recovery and manageable, transient cardiovascular effects.